Recent advances of chimeric antigen receptor T-cell therapy for acute myeloid leukemia.

Front Immunol · 2025 · PMC12081463 · PMID 40386773

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

For example, developing more effective CAR structure may be significant potential for advancement.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.